Elligo Clin Res Centre
Austin, Texas 78704
1 studies enrolling now · 7 studies all time
What they study most
Diabetes Mellitus, Type 2, Obesity, Overweight, Type 2 Diabetes
Studies at this site
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events — Recruiting now
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight — Withdrawn before enrolling
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight — Completed
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) — Completed
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise — Completed
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight — Completed
- A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes — Completed